A detailed history of Primecap Management CO transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Primecap Management CO holds 35,500 shares of PRTA stock, worth $540,310. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,500
Previous 36,500 2.74%
Holding current value
$540,310
Previous $753,000 21.25%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$16.73 - $24.79 $16,730 - $24,790
-1,000 Reduced 2.74%
35,500 $593,000
Q1 2024

May 13, 2024

BUY
$24.75 - $40.66 $903,375 - $1.48 Million
36,500 New
36,500 $904,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $714M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.